French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy

Saved in:
Bibliographic Details
Published in:The journal of gene medicine 2003-01, Vol.5 (1), p.82-84
Main Author: European Society of Gene Therapy
Format: Article
Language:English
Subjects:
Clinical Trials as Topic
Clinical Trials Data Monitoring Committees
Europe
Genetic Diseases, X-Linked - genetics
Genetic Diseases, X-Linked - therapy
Genetic Therapy - adverse effects
Genetic Therapy - legislation & jurisprudence
Humans
Severe Combined Immunodeficiency - genetics
Severe Combined Immunodeficiency - therapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 84
container_issue 1
container_start_page 82
container_title The journal of gene medicine
container_volume 5
creator European Society of Gene Therapy
description
doi_str_mv 10.1002/jgm.364
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72961321</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72961321</sourcerecordid><originalsourceid>FETCH-LOGICAL-c239t-5ede2a68f8c7a3dc8820568a2985814fff56d5a230ec42236001c6ce53f613ca3</originalsourceid><addsrcrecordid>eNpVkd1q3DAQhUVIaX5a8gZFV2l64a1-LK98WbZJGgi0kBT2zijyaKPUkhxJDuxb9pEiZxdKbzQS8805gw5CZ5QsKCHs69PGLXhTH6BjKhitGBP1YbmTtq3qVq6P0ElKT4TQpZTte3REmaANEfUx-nsVwetHvAEPOD9CVOMWb2KYRhxhDDEnHPzcwKp_gZgAwwv4jK3HCuvBeqvVgHO05QzmfxkTIl5XhfkDPU5lLgLWwT1YX97WuamwPRirbVlhiy_W1d3q5vuXBf4Vks22-KasMrjZz8Tg3ta4nGIYQXl8F8pc3s6u17Pr_c71A3pn1JDg476eot9Xl_erH9Xtz-ub1bfbSjPe5kpAD0w10ki9VLzXUjIiGqlYK4WktTFGNL1QjBPQNWO8KZ-nGw2Cm4ZyrfgpOt_pjjE8T5By52zSMAzKQ5hSt2RtARkt4OcdqGNIKYLpxmidituOkm4OryvhdSW8Qn7aS04PDvp_3D4t_gpmM5gf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72961321</pqid></control><display><type>article</type><title>French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>European Society of Gene Therapy</creator><creatorcontrib>European Society of Gene Therapy</creatorcontrib><identifier>ISSN: 1099-498X</identifier><identifier>EISSN: 1521-2254</identifier><identifier>DOI: 10.1002/jgm.364</identifier><identifier>PMID: 12516054</identifier><language>eng</language><publisher>England</publisher><subject>Clinical Trials as Topic ; Clinical Trials Data Monitoring Committees ; Europe ; Genetic Diseases, X-Linked - genetics ; Genetic Diseases, X-Linked - therapy ; Genetic Therapy - adverse effects ; Genetic Therapy - legislation &amp; jurisprudence ; Humans ; Severe Combined Immunodeficiency - genetics ; Severe Combined Immunodeficiency - therapy</subject><ispartof>The journal of gene medicine, 2003-01, Vol.5 (1), p.82-84</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12516054$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>European Society of Gene Therapy</creatorcontrib><title>French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy</title><title>The journal of gene medicine</title><addtitle>J Gene Med</addtitle><subject>Clinical Trials as Topic</subject><subject>Clinical Trials Data Monitoring Committees</subject><subject>Europe</subject><subject>Genetic Diseases, X-Linked - genetics</subject><subject>Genetic Diseases, X-Linked - therapy</subject><subject>Genetic Therapy - adverse effects</subject><subject>Genetic Therapy - legislation &amp; jurisprudence</subject><subject>Humans</subject><subject>Severe Combined Immunodeficiency - genetics</subject><subject>Severe Combined Immunodeficiency - therapy</subject><issn>1099-498X</issn><issn>1521-2254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNpVkd1q3DAQhUVIaX5a8gZFV2l64a1-LK98WbZJGgi0kBT2zijyaKPUkhxJDuxb9pEiZxdKbzQS8805gw5CZ5QsKCHs69PGLXhTH6BjKhitGBP1YbmTtq3qVq6P0ElKT4TQpZTte3REmaANEfUx-nsVwetHvAEPOD9CVOMWb2KYRhxhDDEnHPzcwKp_gZgAwwv4jK3HCuvBeqvVgHO05QzmfxkTIl5XhfkDPU5lLgLWwT1YX97WuamwPRirbVlhiy_W1d3q5vuXBf4Vks22-KasMrjZz8Tg3ta4nGIYQXl8F8pc3s6u17Pr_c71A3pn1JDg476eot9Xl_erH9Xtz-ub1bfbSjPe5kpAD0w10ki9VLzXUjIiGqlYK4WktTFGNL1QjBPQNWO8KZ-nGw2Cm4ZyrfgpOt_pjjE8T5By52zSMAzKQ5hSt2RtARkt4OcdqGNIKYLpxmidituOkm4OryvhdSW8Qn7aS04PDvp_3D4t_gpmM5gf</recordid><startdate>200301</startdate><enddate>200301</enddate><creator>European Society of Gene Therapy</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200301</creationdate><title>French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy</title></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c239t-5ede2a68f8c7a3dc8820568a2985814fff56d5a230ec42236001c6ce53f613ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Clinical Trials as Topic</topic><topic>Clinical Trials Data Monitoring Committees</topic><topic>Europe</topic><topic>Genetic Diseases, X-Linked - genetics</topic><topic>Genetic Diseases, X-Linked - therapy</topic><topic>Genetic Therapy - adverse effects</topic><topic>Genetic Therapy - legislation &amp; jurisprudence</topic><topic>Humans</topic><topic>Severe Combined Immunodeficiency - genetics</topic><topic>Severe Combined Immunodeficiency - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>European Society of Gene Therapy</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of gene medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><aucorp>European Society of Gene Therapy</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy</atitle><jtitle>The journal of gene medicine</jtitle><addtitle>J Gene Med</addtitle><date>2003-01</date><risdate>2003</risdate><volume>5</volume><issue>1</issue><spage>82</spage><epage>84</epage><pages>82-84</pages><issn>1099-498X</issn><eissn>1521-2254</eissn><cop>England</cop><pmid>12516054</pmid><doi>10.1002/jgm.364</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1099-498X
ispartof The journal of gene medicine, 2003-01, Vol.5 (1), p.82-84
issn 1099-498X
1521-2254
language eng
recordid cdi_proquest_miscellaneous_72961321
source Wiley-Blackwell Read & Publish Collection
subjects Clinical Trials as Topic
Clinical Trials Data Monitoring Committees
Europe
Genetic Diseases, X-Linked - genetics
Genetic Diseases, X-Linked - therapy
Genetic Therapy - adverse effects
Genetic Therapy - legislation & jurisprudence
Humans
Severe Combined Immunodeficiency - genetics
Severe Combined Immunodeficiency - therapy
title French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T12%3A12%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=French%20gene%20therapy%20group%20reports%20on%20the%20adverse%20event%20in%20a%20clinical%20trial%20of%20gene%20therapy%20for%20X-linked%20severe%20combined%20immune%20deficiency%20(X-SCID).%20Position%20statement%20from%20the%20European%20Society%20of%20Gene%20Therapy&rft.jtitle=The%20journal%20of%20gene%20medicine&rft.aucorp=European%20Society%20of%20Gene%20Therapy&rft.date=2003-01&rft.volume=5&rft.issue=1&rft.spage=82&rft.epage=84&rft.pages=82-84&rft.issn=1099-498X&rft.eissn=1521-2254&rft_id=info:doi/10.1002/jgm.364&rft_dat=%3Cproquest_cross%3E72961321%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c239t-5ede2a68f8c7a3dc8820568a2985814fff56d5a230ec42236001c6ce53f613ca3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=72961321&rft_id=info:pmid/12516054&rfr_iscdi=true